TrialClinical and translational science2024

Pharmacokinetics and safety of erenumab in pediatric patients with migraine: A phase I, randomized, open-label, multiple-dose study.

Andrew D Hershey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.